Beta-blockade intolerance in anthracyclin-induced cardiomyopathy

International Journal of Cardiology

Volumn 106, Issue 1, 2006, Pages 132-134

  Tabet, Jean Yves ^a   Meurin, Philippe ^a   Driss, Ahmed Ben ^a   Berthaux, Xavier ^b   Weber, Hélène ^a   Renaud, Nathalie ^a   Cohen Solal, Alain ^c  

^a Centre de Readaptation Cardiaque de la Brie   (France)

^b Clinique de Tournan   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Anthracyclin; Beta blocker treatment; Cardiomyopathy

Indexed keywords

ANTHRACYCLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CREATININE; DOXORUBICIN; ENALAPRIL; FLUINDIONE; FUROSEMIDE; PIRARUBICIN; SPIRONOLACTONE;

ACUTE HEART FAILURE; ADULT; ANAMNESIS; ARTICLE; BLOOD PRESSURE; BREAST CARCINOMA; CARDIOMYOPATHY; CASE REPORT; CREATININE BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; FORWARD HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART RATE; HOSPITALIZATION; HUMAN; HYPOKINESIA; LUNG ARTERY PRESSURE; MASTECTOMY; MITRAL VALVE REGURGITATION; PLEURA METASTASIS; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ANTHRACYCLINES; BREAST NEOPLASMS; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; MIDDLE AGED;

EID: 28444474206     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.12.052     Document Type: Article

References (9)

1. The cardiac insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
2. Effect of metoprolol CR / XL in chronic heart failure: Metoprolol CR / XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
3. S.A. Hunt, D.W. Baker, M.H. Chin, M.P. Cinquegrani, A.M. Feldman, and G.S. Francis ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) J Am Coll Cardiol 38 2001 2101 2113
4. S.A.O.H. Mortensen, and U. Baandrup Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease Br Heart J 55 1986 274 282
5. S. Fazio, E.A. Palmieri, B. Ferravante, F. Bone, B. Biondi, and L. Sacca Doxorubicin-induced cardiomyopathy treated with carvedilol Clin Cardiol 21 1998 777 779
6. R.E. Shaddy, S.L. Olsen, M.R. Bristow, D.O. Taylor, E.A. Bullock, and L.Y. Tani Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients Am Heart J 129 1995 197 199
7. A. Noori, J. Lindenfeld, E. Wolfel, D. Ferguson, M.R. Bristow, and B.D. Lowes Beta-blockade in adriamycin-induced cardiomyopathy J Card Fail 6 2000 115 119
8. M. Cohen, I. Kronzon, and A. Lebowitz Reversible doxorubicin-induced congestive heart failure Arch Intern Med 142 1982 1570 1571
9. J. Saini, M.W. Rich, and A.P. Lyss Reversibility of severe left ventricular dysfunction due to doxorubicin cardiotoxicity. Report of three cases Ann Intern Med 106 1987 814 816